reference/13522427

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13522427

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, P.H.S.
endingPage	1928
issn	0008-543X 1097-0142
issueIdentifier	9
pageRange	1921-1928
publicationName	Cancer
startingPage	1921
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_594635660b85e5edaa9638c429bbd403 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ab565984d309aebef94b58046b90d633 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a0c97dd8bc94a98017c58111ae150746 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a4f0af33ae55cb9496baca2b09feb079 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9bf9dd4a92652d24bc69b64f4927b75f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_26b1d2830af64ebf721d972c41b398ba
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_626b65cbc4d88fd852cbbf1cf4e92608 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_301f7574b4957811ca9f6aafa24203e9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fb723d60850f2e8c4af4e2300c8b64ee http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_82b30a0930efc6dd22d386f02739fc09 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_81df77b67a683b64725d2837737e1f78 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7ef1913e4e848f6fef4d61bcdb2b475f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e7b1d03948df994c929a81e36a2446b0
bibliographicCitation	Dall'Era MA, Lo MJ, Chen J, Cress R, Hamilton AS. Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer. Cancer. 2018 May 01;124(9):1921–8. PMID: 29499075; PMCID: PMC7492103.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20919c13e9f1baa502f34937180cc03d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2157efa857cb15ca99e77f625d42bded http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2301-2683 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed9e1e04142eb2c86c981c50e0cdda22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe27a6c452dfa123d2278425118fb1c1
date	2018-03-02^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7492103 https://doi.org/10.1002/cncr.31285 https://pubmed.ncbi.nlm.nih.gov/29499075
isPartOf	https://portal.issn.org/resource/ISSN/0008-543X https://portal.issn.org/resource/ISSN/1097-0142 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Nine‐year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0028300
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000726Q000627 http://id.nlm.nih.gov/mesh/D011468 http://id.nlm.nih.gov/mesh/D011471Q000382 http://id.nlm.nih.gov/mesh/D018931Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000072700Q000379 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D012042Q000706 http://id.nlm.nih.gov/mesh/D011471Q000473 http://id.nlm.nih.gov/mesh/D011471Q000628 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D059248Q000379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014481Q000453 http://id.nlm.nih.gov/mesh/D011467Q000473 http://id.nlm.nih.gov/mesh/D011467Q000601 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983

Showing number of triples: 1 to 65 of 65.